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Collagens are the main structural component of the extra-
cellular matrix and provide biomechanical properties to con-
nective tissues. A critical step in collagen fibril formation is
the proteolytic removal of N- and C-terminal propeptides
from procollagens by metalloproteinases of the ADAMTS
(a disintegrin and metalloproteinase with thrombospondin
motifs) and BMP1 (bone morphogenetic protein 1)/Tolloid-
like families, respectively. BMP1 also cleaves and activates
the lysyl oxidase (LOX) precursor, the enzyme catalyzing
the initial step in the formation of covalent collagen cross-
links, an essential process for fibril stabilization. In this
study, using murine skin fibroblasts and HEK293 cells, along
with immunoprecipitation, LOX enzymatic activity, solid-
phase binding assays, and proteomics analyses, we report that
the LOX precursor is proteolytically processed by the procol-
lagen N-proteinases ADAMTS2 and ADAMTS14 between
Asp-218 and Tyr-219, 50 amino acids downstream of the
BMP1 cleavage site. We noted that the LOX sequence
between the BMP1- and ADAMTS-processing sites contains
several conserved tyrosine residues, of which some are post-
translationally modified by tyrosine O-sulfation and contrib-
ute to binding to collagen. Taken together, these findings
unravel an additional level of regulation in the formation of
collagen fibrils. They point to a mechanism that controls the
binding of LOX to collagen and is based on differential
BMP1- and ADAMTS2/14-mediated cleavage of a tyrosine-
sulfated domain.
The extracellularmatrix (ECM)5 is a complex scaffold result-
ing from the association of diverse macromolecules produced
and secreted by cells into the surrounding medium. This ECM
not only provides structural support for resident cells but also
influences various cellular processes, including proliferation,
adhesion, migration, and differentiation, as well as plays key
roles in homeostasis and the regeneration of tissues and organs
(1). Although the composition of the ECM can vary markedly,
collagens are the main component conforming the structural
matrix core and are fundamental to providing the connective
tissues with their biomechanical properties. In vertebrates,
28 types of collagens have been described (I–XXVIII), which
are classified into several families, including the fibrillar
collagen family (I–III, V, XI, XXIV, and XXVII) and basement
membrane-forming collagen IV (2). Fibrillar collagens form
homotrimeric (three identical-chains) or heterotrimeric (two
or three distinct polypeptide chains) molecules. Each -chain
consists of a major uninterrupted triple helical or collagenous
domain (characterized by a repetition of Gly-Xaa-Yaa triplets,
where Xaa and Yaa are commonly proline and hydroxyproline,
respectively) flanked by N- and C-terminal noncollagenous
domains, the N- and C-propeptides (3). Once synthesized in
the endoplasmic reticulum, these collagen chains are brought
together in a process governed by the C-propeptides and folded
to form the procollagen molecule. Upon transit through the
Golgi network and extracellular secretion, the N- and C-pro-
peptides are cleaved off, respectively, by the procollagenN-pro-
teinases belonging to the ADAMTS (a disintegrin and metallo-
proteinase with thrombospondin motifs) family (ADAMTS2,
-3, and -14) and by C-proteinases, which are BMP1 (bone mor-
phogenetic protein 1)/Tolloid-like enzymes. These proteolytic
events yield triple helical collagen molecules that retain only a
short portion of the propeptides, the telopeptides, and are able
to assemble into fibrils, the most recognizable signature of col-
lagen-based extracellular structures (3).
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The mechanical strength of the extracellular collagenous
matrix is highly dependent on the formation of covalent cross-
links within fibrils, a process initiated by the enzymatic action
of lysyl oxidase (LOX) (4). LOX catalyzes the oxidative deami-
nation of lysine and hydroxylysine residues within the telopep-
tide domains, yielding the corresponding aldehydes, which
eventually condense with other oxidized groups or intact
lysines to form a variety of inter- and intrachain cross-linkages.
Five different LOX enzymes have been identified in mammals
(LOX and LOX-like 1–4), with the canonical LOX being the
isoformmost clearly associated with the remodeling and stabil-
ity of the collagen matrix, described to play important roles in
fibrosis, tumor microenvironment, and tissue repair (5, 6).
Proteolysis is crucial in the process of collagen synthesis and
assembly. Not only are proteolytic events responsible for the
removal of the propeptides, but also one of involved proteases,
namely BMP1, cleaves the LOX precursor to generate the pro-
peptide, for which biological activities have been also reported,
and the fully active LOX (7–10). This simple picture is, how-
ever, challenged by experimental evidence showing that differ-
ent mature forms co-exist and contribute to LOX-mediated
actions (11–14). The molecular mechanisms leading to this
behavior, which may arise not only by alternative proteolytic
processing but also because of post-translational modifications
(PTM), have not been established, and its study might indeed
shed fresh light on the biological function of LOX. In this con-
text, we recently identified, using a large-scale and nonbiased
approach, that LOX is a potential substrate of ADAMTS14,
although a complete characterization of this potential proteol-
ysis remains to be investigated, as well as its relevance in the
regulation of LOX (15).
Here, we describe that LOX is proteolytically processed by
ADAMTS2 and -14, but not ADAMTS3, between residues
Asp-218 and Tyr-219, at a site located 50 amino acids down-
stream of the well-characterized BMP1 cleavage site. Protein
segment flanked by both processing sites contains a number of
conserved tyrosine residues that can be potentially modified by
tyrosineO-sulfation, which we confirmed by different method-
ological approaches, including proteomic characterization.
Althoughwe have shown that the LOXprecursor and the forms
processed by BMP1 or ADAMTS2/14 proteases displayed
similar enzymatic activity on a soluble substrate, they substan-
tially differed in their capacity to bind collagen, with the sulfo-
tyrosine residues playing an important role in the interaction.
Taken together, these results point to a mechanism for the
regulation of the binding and the activity of LOX on colla-
gen, resulting from the differential cleavage by BMP1 and
ADAMTS2/14 of a tyrosine sulfate domain.
Results
LOX is expressed inmultiple forms
By using a polyclonal antibody that specifically recognizes
the C-terminal end of LOX protein, we have analyzed the elec-
trophoretic pattern of LOX secreted from human lung fibro-
blasts and bovine endothelial cells incubated for 4 days in the
presence or absence of the cytokine transforming growth fac-
tor-1 (TGF-1), a well-known activator of LOX expression
(16). As shown in Fig. 1A, the supernatant of fibroblasts or
endothelial cells showedmultiple immunoreactive bands rang-
ing from 25 to 30 kDa, whose levels strongly increased upon
incubationwithTGF-1. To analyze how this pattern arises, we
have generated a human embryonic kidney (HEK) 293 cell
clone stably expressing a human LOX construct under tetra-
cycline-dependent control. Fig. 1B shows the LOX immunore-
activity associated with cells (cell extract) or secreted into the
extracellularmedium (supernatant) in basal conditions or upon
stimulation with doxycycline, a tetracycline analog. Although
only a very faint band of about 50 kDa, corresponding to the
intracellular precursor, was observed in the extracts from stim-
ulated cells, significantly higher levels were secreted to the
extracellular medium, including the precursor and multiple
bands at 25–30 kDa. In contrast to fibroblast and endothelial
cultures, where precursor bands were not detected under our
experimental conditions, HEK293 cell clone displayed a limited
capacity to process LOX as indicated by the accumulation of
the unprocessed form, a circumstance providing the possibility
to use this cell line to analyze themolecular events associated to
the generation of mature forms.
ADAMTS2 and -14 proteolytically process LOX
Wehave previously identified LOXas a potential substrate of
ADAMTS14 in the secretome of human fibroblasts (15). Here,
we used two methodological approaches to characterize the
ability of the procollagen N-proteinases, ADAMTS2, -3, and
-14, to cleave LOX.Having generatedHEK293 cell clones stably
expressing the human forms of these ADAMTS proteases only
in the presence of doxycycline (Fig. S1), we co-cultured them
withHEK293 cells able to conditionally secrete LOX.After 48 h
of co-culture with or without doxycycline, the LOXpatternwas
evaluated by immunoblotting (Fig. 2, A and B). Expression of
ADAMTS2 and ADAMTS14 resulted in a relative enrichment
Figure 1. LOX isoform is expressed inmultiple forms.A,human lung fibro-
blasts and bovine vascular endothelial cells were incubated for 4 days under
basal conditionsor in thepresenceof 5ng/ml TGF-1. Then, cell supernatants
were taken and concentrated using a 10-kDa cutoff centrifugal filter. An ali-
quot was fractioned by SDS-PAGE and assayed by immunoblotting with a
specific LOX antibody recognizing the C-terminal catalytic domain. Multiple
immunoreactive bands were observed with molecular masses ranging from
25 to 30 kDa. B, generation of HEK293 cells overexpressing human LOX in a
tetracycline inducible manner. LOX protein in the total cell extract and in the
supernatant was assessed by immunoblotting under basal conditions and
upon induction with the tetracycline analog, Dox. The precursor form at 50
kDa and multiple shorter forms (at 25–30 kDa) are identified in the culture
medium of Dox-treated cells. The blots shown correspond to representative
experiments performed twice with two independent preparations.
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ofmature forms of LOX around 25 kDa, at the expense of bands
at 30 kDa, strongly suggesting a proteolytic processing. Such
cleavage was not observed for ADAMTS3. It has to be men-
tioned thatHEK293 cells display significant endogenousBMP1,
which explains the conversion of precursor LOX into forms
migrating around 30 kDa. We have also established an in vitro
assay for the analysis of LOX cleavage by incubation of concen-
trated supernatants from LOX-overexpressing clone and puri-
fied preparations of ADAMTS2 andADAMTS14, and we com-
pared their effects with that of concentrated supernatants from
HEK293 cells overexpressing BMP1 (Fig. S1 and Fig. 2, C and
D). Similar to data obtained in co-cultures, incubation with
ADAMTS2 and ADAMTS14 resulted in a time-dependent
reduction of the abundance of the 50-kDa LOX precursor
and a concomitant accumulation of the mature form at 25
kDa. In contrast, incubation with BMP1 led to an enrich-
ment of the processed forms around 30 kDa, clearly indicating
that ADAMTS enzymes process LOX in a different location,
presumably downstream from the established BMP1 site. This
aspect was further confirmed by complete proteolysis by BMP1
and addition of ADAMTS14 on top of the BMP1-processed
form (Fig. 2E).
We then applied a proteomic approach to determine at
which site LOX is cleaved by ADAMTS2/14. For that pur-
pose, LOX supernatants exposed to ADAMTS2 were filtered
through a 50-kDa-cutoff centrifugal filter to enrich the samples
in LOX mature forms (Fig. S2). Flow-throughs were trypsin-
digested, and peptides were analyzed by MS (Fig. 3). Several
LOX peptides were identified that resulted from trypsin diges-
tion at both their N- and C-terminal ends, except one hemit-
ryptic (a peptide cleaved by trypsin in one end and another
protease in the other end), i.e. cleaved by trypsin at the C ter-
minus but not at the N terminus, presumably obtained by
ADAMTS2-dependent action. In fact, careful inspection of this
potential processing site within the LOX sequence revealed its
location 50 residues downstream of the well-established BMP1
site, an observation that fully matches with the molecular
weight of the ADAMTS2/14-processed form as observed by
immunoblotting. Analysis of LOX protein sequence shows that
both BMP1 (MVG/DDP) and ADAMTS (VAD/PYY) sites are
well-conserved among several organisms (Fig. 4). Interestingly,
the Asp/Pro scissile bond cleaved by ADAMTS2 and -14 is also
conserved in LOX forms evolutionarily close to the canonical
LOX, such as lysyl oxidase-like (LOXL) isoform 1 or the
zebrafish LOXL5 (a sort of hybrid LOX/LOXL1 uniquely pres-
ent in this teleost fish). By contrast, the more evolutionarily
distant LOXL2, LOXL3, andLOXL4 isoformsdisplay nohomo-
logy in the corresponding position, despite the overall conser-
vation observed in the downstream catalytic domain (5). This
observation predicts that LOXL1 andLOXL5proteinsmight be
also substrates of ADAMTS proteases.
To evaluate LOXcleavage byADAMTS2 andADAMTS14 in
a relevant cell model, we used skin fibroblasts isolated from
wildtype (WT) and Adamts2–Adamts14-deficient mice (17).
These fibroblasts were left untreated or were incubated with
TGF-1 (5 ng/ml during 48 h). Conditioned media were then
analyzed by immunoblotting. As shown in Fig. 5, forWT fibro-
blasts incubated with TGF-1, the vast majority of the LOX
signal was detected around 25 kDa, which corresponds to the
ADAMTS2/14 processed forms. By contrast, upon induction
with TGF-1, fibroblasts from the double knockout showed a
diminishing of the 25-kDaproductwith respect toWT,without
significantly affecting the BMP1 product at 30 kDa, which dem-
Figure 2. Cleavage of LOX by ADAMTS2 andADAMTS14. LOX cleavagewas assayed by immunoblotting in LOX/ADAMTS-overexpressing co-cultures after
incubation with doxycycline for 48 h (A and B) and after in vitro incubation assays (C andD) for the indicated times. For comparison, LOX fragments generated
upon incubation with BMP1 are also shown in C. ADAMTS2 and ADAMTS14, either in co-culture or using purified proteins, promoted the accumulation of a
mature form of about 25 kDa (red arrow), whereas BMP1 cleavage gave rise to bands in the 30-kDa range (blue arrow), indicating distinct processing sites.
ADAMTS3 co-culture did not modify the relative levels of both fragments, suggesting it was not able to process LOX under our experimental conditions. E,
sequential incubation with BMP1 and ADAMTS14. LOX supernatant was first incubated with BMP1 for 1 h. Then, ADAMTS14 was added into the reaction
mixture for the indicated times.
LOX cleavage regulates collagen binding
J. Biol. Chem. (2019) 294(29) 11087–11100 11089
 at CSIC on D
ecem
ber 12, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
onstrates the participation of ADAMTS2/14 in the maturation
of LOX.
Identification of tyrosine sulfation in the region of LOX protein
flanked by BMP1 and ADAMTS2/14 processing sites
Examination of the LOX immunoreactive bands throughout
this study showed that they are actually formed by multiple
molecular species differing slightly in their electrophoretic
mobility, a behavior typically arising from extensive PTM. We
have investigated this possibility by two-dimensional (2D) elec-
trophoresis followed by immunoblotting. As shown in Fig. 6,
precursor and mature forms of LOX are visualized as several
spots. Interestingly, LOX precursor at 50 kDa, with a theoreti-
cal isoelectric point (pI) of 7.99, gave rise to a train of spots at a
muchmore acidic pI, an observation indicating the presence of
PTM added extra negative charges (Fig. 6A). Upon cleavage
with the BMP1 enzyme, the most acidic part of this series of
spots is kept, whereas the digestion with ADAMTS2 collapsed
these species into a single spot at a more basic pI (Fig. 6, B and
C). These observations are compatible with the findings that
the presence of the PTM caused the acidic shift within the pro-
tein region flanked by BMP1 and ADAMTS sites. This region,
depicted in Fig. 7A, represents a unique tract within LOX
sequence as it contains 12 tyrosines in a 50-amino acid–long
segment, most of them well-conserved among different LOX
orthologs (see Fig. 4). Tyrosine O-sulfation is one of the PTMs
known to add extra negative charges and has been increasingly
recognized as an important regulator of protein–protein inter-
actions in the extracellular space (18, 19). In fact, tyrosine sul-
fation of LOX in this particular location has been previously
suggested but, to our knowledge, not thoroughly investigated
(20). Analysis of LOX sequence using Sulfinator, a software
used to predict tyrosine sulfation sites, revealed candidate
tyrosines for this modification in a cluster within this region
(Fig. 7A) (21). As a first approach to investigate whether these
tyrosine residues become sulfated, we have altered the LOX
sequence by changing tyrosines into phenylalanines, which
blocked sulfation, and analyzed the mutant protein by immu-
noblotting under control conditions and after processing with
BMP1 and ADAMTS enzymes. As shown in Fig. 7B (left), the
precursor of this LOX mutant in the tyrosine cluster showed
a slightly increased electrophoreticmobility comparedwith the
WT precursor, an effect much more evident in the forms pro-
cessed by BMP1. In contrast, the products resulting from
ADAMTS2 cleavage migrated similarly for both WT and
mutant proteins. Altogether, these observations suggest that
these tyrosine residues are the target of a particular chemical
modification, and its mutation abolishes this effect. This inter-
pretation is further supported by 2D electrophoresis showing
that LOX spots corresponding to the precursor band and the
BMP1-processed form were shifted to the right in the mutant,
whereas both WT and mutant forms accumulated into the
same spot after proteolysis with ADAMTS2 (Fig. S3). Evidence
Figure 3. Proteomic characterization of the ADAMTS-mediated cleavage site in LOX protein. LOX supernatants exposed to ADAMTS2 were enriched in
LOX mature forms by passing through a 50-kDa cutoff centrifugal filter. Then, the flow-throughs were trypsin-digested, and the resulting peptides were
fractionated by LC and analyzed by MS. A, peptide coverage along the human LOX sequence showing identified tryptic fragments (shown in bold) as well-as
a hemitryptic peptide that resulted from the action of ADAMTS2 (yellow, fragment ion spectra in B). C, schematic representation of the cleavage site by BMP1
(blue arrow and arrowhead in A) and ADAMTS2/14 (red arrow and arrowhead in A) within LOX. The cleaved sequences and the theoreticalmolecular weights of
the LOX forms generated by these cleavages are also provided.
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for a sulfotyrosine modification was additionally obtained by
using an antibody recognizing this particular PTM. As
shown in Fig. 7B (right), this antibody positively stained the
form processed by BMP1 in the WT but not in the mutant
protein, leaving unstained the ADAMTS2-processed forms.
Because our antibodies are not efficient for immunoprecipi-
tation, we then generated LOX fused to green fluorescent
protein (GFP). First, as shown in Fig. 7C, we confirmed that
LOX–GFP chimeras behaved essentially as the correspond-
ing formswithout theGFP-tag, i.e. both forms are substrates for
BMP1 and ADAMTS2 proteases, and tyrosine residues are the
subject of a PTMmodifying the electrophoreticmobility of pre-
cursor and the BMP1-processed forms. Then, these cell clones
were metabolically labeled with inorganic [35S]sulfate, and the
labeling of LOXproteinswas determined after immunoprecipi-
tation by electrophoresis and autoradiography. As shown in
Fig. 7D (left), sulfated polypeptides corresponding to BMP1-
processed forms were identified for the WT LOX–GFP,
whereas no labeling of the ADAMTS2-cleaved product was
observed. Despite the proven ability of the anti-GFP beads to
Figure 4. Multiple sequence alignments of ADAMTS cleavage site and flanking sequences. A, sequence alignment of LOX orthologs from the indicated
species showing high homology at the ADAMTS and BMP1 cleavage sites and also in between. B, sequence alignment of ADAMTS cleavage site and down-
stream sequences from LOX orthologs and paralogs from the indicated species. Of note is the high degree of homology observed between the cleavage site
characterized inhumanLOXandcorresponding sequencesof humanLOXL1and the zebrafish LOX, LOXL1, andLOXL5 isoforms.On the contrary, no significant
homology was found among LOXL2, LOXL3, and LOXL4 paralogs, despite the conservation observed in the downstream histidine-rich catalytic core. Protein
alignments were done with the ClustalW2 program (http//www.ebi.ac.uk; please note that the JBC is not responsible for the long-term archiving and main-
tenance of this site or any other third party hosted site.
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pull down the LOX proteolytic fragments in the LOX–GFP
mutant protein (Fig. 7D, right), no radioactive-labeled bands
were detected for this chimera. Finally, we have also performed
a proteomic characterization of immunoprecipitated LOX–
GFP bands resulting from proteolysis with BMP1 by parallel-
reactionmonitoring (PRM). Because of restrictions imposed by
sequence, instead of performing a conventional digestion with
trypsin, we processed protein bands with AspN, and therefore,
we could only analyze the peptide DDNPYYNYY (Figs. S4 and
S5). By comparison with synthetic peptides harboring sulfoty-
rosines at different positions, we were able to unambiguously
detect the sulfuryl moiety in the last tyrosine residue of this
peptide (Tyr-187), and also in one of the previous doublet, with
no distinction of the exact position (Tyr-183 or Tyr-184). Dis-
ulfotyrosine peptides were not detected, most likely because
negatively charge residues cannot stay in close proximity.
Taken together, these results demonstrate that tyrosine res-
idues in the LOX sequence flanked by cleavage sites for BMP1
and ADAMTS2/14 undergo sulfation, a modification that
potentially can influence the biological properties of the LOX
enzyme.
Biological effect of the proteolytic processing of LOX:
contribution of the tyrosine-sulfated domain for binding to
collagen
Having demonstrated that LOX is processed by ADAMTS2/
14, we investigated the contribution of this cleavage to the
enzymatic activity while comparing with the effect of BMP1.
LOX enzymatic activity was determined in an in vitro assay
using a soluble substrate through detection of peroxide in a
horseradish peroxidase (HRP)-coupled real-time reaction (22).
Using this method, we observed that supernatants from doxy-
cycline-induced HEK293 cells displayed strong increases in
LOX activity compared with supernatants from cells left under
basal conditions, which is clearly attributed to the induction of
the expression of LOX protein (Fig. 8A). The presence of
-aminopropionitrile (BAPN, LOX inhibitor) resulted in a
complete inhibition of this induction, which further demon-
strated the specificity and relevance of the assay (Fig. 8, A and
B). As also shown in Fig. 8, incubation of LOXwith ADAMTS2
did not significantly modify its activity. To our surprise, treat-
mentwith BMP1, thewell-established activator of LOX, left the
activity essentially unchanged. Therefore, in contrast to previ-
ous assumptions, these observations suggest that the precursor
is catalytically active and that the processing by BMP1 or
ADAMTS enzymes does not substantially enhance this intrin-
sic enzymatic activity. In addition to elastin and collagen sub-
strates, LOX enzyme can also oxidize a variety of mono- or
diamines of various carbon chain lengths (23, 24). Given the
apparent flexibility of substrate requirements, which has per-
mitted the development of a convenient (and widely used)
HRP-coupled assay, our observations suggest that, rather than
the enzymatic capacity of the LOX protein, proteolysis may
determine the interaction with substrates, and thereby restrict
its activity in vivo on collagen and elastin (22). We have there-
fore investigated the capacity of the precursor and processed
forms of WT and tyrosine-mutated LOX to bind collagen in a
modified solid-phase binding assay. HEK293-derived secre-
tomes used in our studies do not contain pure LOX species, but
rather a mixture resulting from the action of endogenous pro-
teases, a confounding variable that can potentially give errone-
ous values in a standard colorimetric assay. For this reason,
LOX-containing supernatants were incubated with immobi-
lized collagens, either bearing telopeptides (telocollagen) or not
(atelocollagen). Bound material was then collected and ana-
lyzed by SDS-PAGE coupled to immunoblotting. Using this
Figure 5. LOX cleavage in skin fibroblasts from WT and Adamts2–
Adamts14-deficient mice. Accumulation of LOX mature forms in the extra-
cellular mediumwas assayed by immunoblotting in cultured skin fibroblasts
fromwildtype (WT) and doubly-deficient Adamts2–Adamts14 knockout mice
(TS2/TS14/) upon induction with TGF-1 or basal. Note that ADAMTS2/
TS14-deficient cells showed a diminishing of the 25-kDa product (red arrow)
with respect to WT, without significantly affecting the 30-kDa BMP1 product
(blue band) (ratio of band intensities ADAMTS/BMP1:3.71 in the WT; 1.45 in
Adamts2-Adamts14-deficient fibroblasts).
Figure 6. Analysis of LOX proteolysis by two-dimensional electrophore-
sis coupled to immunoblotting. LOX supernatants kept under basal condi-
tions (A) or incubated with BMP1 (B) or ADAMTS2 (C) were fractioned by 1D
(left) or 2D (right) electrophoresis and analyzed by immunoblotting using a
specific C-terminal LOX antibody. LOX precursor was visualized as a train of
spots with the isoelectric point (pI) more acidic than predicted from the
amino acid sequence (7.99). BMP1-cleaved mature form gave a similar pat-
tern (indicated by a red dashed oval), whereas the cleavage by ADAMTS2
resulted in a single prominent spot at a more basic pI (red arrowhead). The
blots showncorrespond to representative experimentsperformed twicewith
two independent preparations.
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Figure 7. Identification of tyrosine sulfation in the LOX protein sequence flanked by BMP1 and ADAMTS2 cleavage sites. A, LOX protein sequence
flanked by BMP1 andADAMTS cleavage sites. Tyrosine residues conserved among LOX/LOXL1 orthologs aremarked in red.Asterisks indicate tyrosines that are
predicted to undergo sulfation by the algorithm Sulfinator. The sequences of the WT and mutant construct with the cluster of tyrosines changed to phenyl-
alanine are also shown. B, cleavage of WT and mutant LOX by BMP1 (BM) and ADAMTS2 (TS) as assessed by immunoblotting with anti-LOX (left) and
anti-sulfotyrosine (right) antibodies. The asterisk indicates the position of an unspecific band recognized by the antibody in both WT and mutant samples
treatedwith BMP1.C,BMP1- andADAMTS2-mediated cleavage ofWT andmutant LOX chimera C-terminally fused toGFP as assessed by immunoblottingwith
an anti-GFP antibody.D, sulfation of tyrosines in LOX variants. HEK293 cells overexpressingWT (left panels) andmutant (right panels) LOX/GFP constructs were
metabolically labeledwith [35S]sulfate. The supernatants were then kept untreated () or incubatedwith BMP1 or ADAMTS2 before immunoprecipitation (IP)
using anti-GFP beads. Inputs and immunoprecipitates were analyzed by immunoblotting with an anti-GFP antibody (upper panels) and by autoradiography
(lower panels). Note that only slow-migrating bands resulting from the action of BMP1 were shown to incorporate radioactivity, whereas the fragment with
higher electrophoreticmobility specifically generated by ADAMTS2was not. Radioactively labeled bands observed in the supernatant treatedwith ADAMTS2
likely represent fragments generated as a result of endogenous BMP1 secreted by HEK293 cells. No specific radioactive labeling was detected in the immu-
noprecipitates frommutant LOX/GFP.
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approach, we could precisely determine the percentage of bind-
ing of the various LOX species (Fig. 8). The LOX precursor
showed a limited capacity to bind telocollagen, and this was not
modified by mutation of the tyrosine-sulfated domain. In con-
trast, BMP1-processed WT LOX displayed a higher binding
capacity, a property thatwasmarkedly reduced for the tyrosine-
mutated LOX, indicating that a substantial part of the interac-
tion goes through these modified residues. Interestingly, the
form processed by ADAMTS2 showed lower binding, and this
was not altered in the mutant. Binding of LOX forms to atelo-
collagenwas lowandremainedessentiallyunchangeduponpro-
teolysis or mutation of tyrosine residues. Taken together, these
results suggest that the differential cleavage of a tyrosine-sul-
fated domain by BMP1 and ADAMTS2/14 determines the
capacity of an active LOX catalytic domain to interact with
collagen and thereby direct it toward specific lysine residues in
the telopeptide domain.
Discussion
The biosynthesis of collagen is a highly complex process
involving numerous events occurring intra- and extracellularly
(3). The final step, fundamental for providing the collagen net-
work with its biomechanical properties, is the introduction of
covalent cross-links, a process initiated by the enzymatic action
of LOX (4). Current knowledge of the biological properties and
functions of LOX is based upon in vitro investigations, mostly
done during early works on matrix biology over the past cen-
tury, and more recently generated in vivo knockout models
(25). Based on this experimentation, it has been shown that
LOX protein is secreted as an inactive precursor that is cleaved
by BMP1 to yield the mature form responsible for the cross-
linking of fibrillar collagens and elastin in the extracellular
matrix of different tissues, mainly the vasculature, skin, and
lung (7–10, 26–28). This study adds new players to this picture
and provides novel structural information about LOX that is
crucial for its biological activity. Here, we demonstrate that
ADAMTS2 and ADAMTS14, two enzymes initially known for
their aminoprocollagen peptidase activity, process LOX pro-
tein in a position downstream of the well-characterized BMP1
cleavage site and that the sequence between these sites contains
a cluster of sulfated tyrosines essential for efficient collagen
binding. Taken together, these data are consistent with the
observation of multiple bands reported in numerous studies
(11–13). They show also that the differential cleavage of LOX
by BMP1 and ADAMTS2/14 modifies its affinity toward colla-
gen and most probably its capacity to oxidize lysine residues in
the telopeptide (Fig. 9). Analysis of the enzymatic activity of the
various LOX species revealed that BMP1- and ADAMTS-me-
diated proteolysis did not significantlymodify the capacity of an
otherwise active precursor to oxidize a soluble substrate. The
intriguing observation that the LOX precursor exhibits full
activity in this assay opposes the widely accepted assumption of
an inactive form becoming active upon cleavage by BMP1
(7–10). However, to our knowledge, no single study in the lit-
erature has shown the cleavage of LOX by BMP1 and the effect
Figure 8. Effect of the proteolysis of LOX on enzymatic activity and collagen-binding capacity. Supernatants from LOX-overexpressing cells under
control conditions (LOX) or exposed to BMP1 or ADAMTS2 were assessed for LOX enzymatic activity in a time-lapse fluorescence assay performed in the
absence (left panel) or presence (right panel) of the LOX inhibitor BAPN (0.3 mM). Basal tracing represents the activity from a supernatant of a culture in the
absence of induction with doxycycline. Representative data (A) and quantification from three independent experiments (B) are shown. Values are shown as
fluorescent arbitrary units (mean S.D., n 6, *, p 0.05 versus basal). C, solid-phase binding assay to telocollagen (with intact telopeptides) or atelocollagen
(without telopeptides) of the various LOX species shown in D. Binding capacity is shown as percentage of total (mean  S.D., n  6, *, p  0.05 versus the
corresponding control without protease treatment, #, p  0.05 versus the corresponding WT). Statistical comparisons between groups were calculated by
one-way ANOVA analysis followed by Bonferroni’s post test.
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on its enzymatic activity in vitro, but rather indirect effects such
as a reduced LOX activity in supernatants from protease-defi-
cient cells, or enhanced LOX activity and processing, together
with augmented insoluble collagen deposition in cells express-
ing higher levels of BMP1 mRNA (8, 29). In this respect, con-
sidering the flexibility of substrate requirements, with LOX
capable of oxidizing not only collagen and elastin but also a
variety of nonpeptidyl amines, we hypothesize that LOX activ-
ity is regulated by the extent of interaction with its different
substrates, rather than by modification of its intrinsic enzy-
matic capacity (23, 24). Consistent with this hypothesis, we
observed increased binding to immobilized collagen upon
BMP1-mediated cleavage as compared with the unprocessed
precursor. Previous studies have shown that the protein has a
higher affinity, and thereby increased oxidation rate, on colla-
gen present as fibrils, rather than in a soluble or denatured form
(30, 31). Therefore, processing by BMP1 potentiates the capac-
ity of LOX to interact with collagen fibrils, positioning the cat-
alytically-active site close to the target lysines in the telopep-
tides. In fact, our experiments showed that LOX is capable of
binding to both telo- and atelocollagen, with BMP1 action
influencing specifically the capacity to interact with telopep-
tide-containing collagen. This is somewhat in contrast with
previous studies showing that LOX exclusively interacts with
the triple helical portion because the apparent binding affinity
for native collagen was found to be quite similar to that for
fibrils prepared frompepsin-digested collagen (30). However, it
should be taken into account that these experiments were done
with bovine aorta LOXpreparations reported to be amixture of
multiple LOX species forwhich precise information about their
individual binding features was not available (11).
An interesting observation of our results is the fact that cleav-
age by ADAMTS2 and -14 substantially diminished the capac-
ity of LOX to bind telocollagen, indicating that an important
part of the binding occurs through sequence determinants
located between the BMP1 and ADAMTS cleavage sites. Using
different methodological approaches, we demonstrate here
that some tyrosine residues within this protein segment are
modified by sulfation. Although our study could not make a
complete characterization of the tyrosine residues present in
this cluster, we succeeded in demonstrating sulfation of at least
two different tyrosines. However, based on our 2D electropho-
resis analyses, it can be anticipated that additional tyrosines
outside this protein segment can also be modified. The impor-
tance of this PTM in the biological function of LOX is high-
lighted by the significant reduction in the collagen-binding
capacity observed for the mutant construct. In fact, tyrosine
sulfation has evolved as an important PTMmediating extracel-
lular protein–protein interactions (18, 19). In the context of the
extracellular matrix, several molecules, including fibromodu-
lin, lumican, osteoadherin, and opticin, have been reported to
contain clusters of sulfated tyrosine residues (32, 33). Particular
attention to fibromodulin is needed as its tyrosine-sulfated
domain has been reported to bind collagen and accelerate fibril
formation (34). Molecular characterization of the binding
properties of fibromodulin has revealed several areas of binding
on the helical portion of type I collagen, with sulfotyrosines
contributing to this interaction. Further mapping using triple-
helical collagen toolkit peptides showed these sites partially
overlap with the helical cross-linking sites (35). In fact, fibro-
modulin has turned out to be an important regulator of collagen
cross-linking because its deficiency results in a dysregulated
enhancement of collagen cross-links, which is associated with
altered mechanical properties of tendinous tissues (36, 37).
Interestingly, fibromodulin was also reported to bind LOX, and
this interaction resulted in an apparent increase in LOXactivity
(35). Based on this information, a model of fibromodulin-regu-
lated collagen cross-linking has been proposedwhere this small
Figure 9. Schematic model describing LOX regulation by BMP1- and ADAMTS-mediated proteolysis in the context of collagen processing. The
diagram summarizes the ability of these proteases to cleave LOX into two different locations yielding mature LOX species with different capabilities to bind
collagen telopeptides based on the presence of a sulfotyrosine domain.
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leucine-rich protein, by forming a ternary complex at the heli-
cal cross-linking sites, directs LOX activity toward specific
lysine residues on the telopeptide of an adjacent microfibril.
Our results are in line with this hypothesis by endowing LOX
protein with the capacity to interact directly with the telopep-
tides. Nevertheless, further experimentation is necessary to
understand how the same PTM drives fibromodulin to the hel-
ical portion or makes LOX able to interact with the telopeptide
ends, as well as whether tyrosine-sulfated domains are involved
or not in the interaction between LOX and fibromodulin.
Proteolysis plays an important role in the homeostasis of
connective tissues, not only by allowing the degradation of
structural components but also by regulating the capacity of a
large array of macromolecules to assemble into a well-orga-
nized physiological ECM. BMP1 and ADAMTS enzymes,
responsible for the processing of procollagen and, as studied
here, of the precursor of LOX protein, have been described to
cleave a wide variety of substrates, most of them belonging to
the ECM category. BMP1 and its related tolloid-like enzymes
were reported to cleave small leucine-rich proteoglycans (big-
lycan and decorin), basement membrane components (such as
laminin), andmineralization factors, including dentin sialopro-
tein and phosphophoryn (38). Additionally, recent work from
our group has significantly expanded the substrate repertoire of
ADAMTS procollagenases with the identification of fibronec-
tin, some fibulins, thrombospondin-1, decorin, and perlecan,
among many others (15). Altogether, these studies permitted
us to establish preferential cleavage sites for these proteases.
Processing by BMP1 seems to be quite restricted, with most
substrates displaying an aspartate in the P1 position (39). For
ADAMTS procollagenases, however, although identified cleav-
age sites were found to be enriched in proline and glycine resi-
dues, a clear consensus sequence has not yet been well-defined
(15). The LOX precursor fulfills the strict aspartate require-
ment for BMP1 proteolysis, and proline is well-represented
within the well-conserved ADAMTS cleavage site in orthologs
fromdifferent species (see Fig. 4). Given the critical role of these
proteases in collagen biosynthesis, gene defects that alter their
expression and/or activity are expected to cause disease. Reces-
sive mutations in BMP1 are linked with recessive forms of
osteogenesis imperfecta, a heterogeneous group of bone disor-
ders characterized by fragile bones that break easily (40). The
ADAMTS2 gene is associated with the dermatosparaxis-type of
Ehlers-Danlos syndrome, a rare condition characterized by
extreme skin fragility (41–43). At themolecular level, both clin-
ical conditions display defective procollagen processing, which
is claimed to be responsible for the production of collagenmol-
ecules with altered structure leading to aberrant matrix in
affected tissues. Collagen cross-linking is likely to be dysregu-
lated in these connective tissue disorders. However, consider-
ing the overall matrix involvement and the fact that these pro-
teases process other matrix components, this aspect has been
poorly investigated. Rare variants in the LOX gene have been
identified that disrupt enzyme function and promote thoracic
aortic aneurysms because of insufficient elastin and collagen
cross-linking in the aortic wall (44, 45). Sequence variations
have been also found that fall within and around the BMP1 and
ADAMTS cleavage sites, or even alter the tyrosine residues
modified by sulfation (46). Their functional consequences have
not yet been investigated. However, it can be speculated that
they can alter the proteolytic activation of LOX or the binding
characteristics of the sulfated domain. Further studies in
patient or animal models will be required to gain insight into
how BMP1, ADAMTS2, and ADAMTS14 coordinately regu-
late collagen processing and cross-linking, as well-as the con-
tribution of these genetic variants to the process.
In conclusion, our data provide novel knowledge about the
proteolytic regulation of LOX functions, linking the differential
action of BMP1 and ADAMTS procollagenases on a sulfated
tyrosine domain to the capacity of LOX to bind and oxidize
collagen in the context of extracellular matrix synthesis and
deposition.
Experimental procedures
Cell culture
Tetracycline (Tet)-inducible HEK293 cells stably expressing
LOX, ADAMTS, and BMP1 constructs were generated and
maintained in culture according to protocols published previ-
ously (15, 47). Human lung fibroblasts from the cell line CCD-
19Lu were obtained from the American Type Culture Collec-
tion (Manassas, VA) and maintained in culture medium as
already described (48). Primary bovine aortic endothelial cells
were isolated from thoracic aortas and maintained in culture
using previously described methods (49).
Skin fibroblast cultures from mice doubly-deficient for
Adamts2 and Adamts14 were established as follows (17). After
sacrifice, mice were shaved and a skin fragment from the belly
of approximately 2 cm2 was collected, washed in 70% ethanol,
transferred in culture hood, rinsed in sterile PBS, and cut into
1-mm2 pieces. Skin fragments were then incubated at 37 °C in
10ml of complete Dulbecco’s modified Eagle’s growthmedium
supplemented with collagenase (Sigma) at 1000 units/ml. After
2 h, 10 ml of complete medium supplemented with 10% fetal
bovine serum (FBS) was added, and centrifugation was per-
formed (5 min at 500  g). The pellet was homogenized by
pipetting in 10 ml of warm complete medium containing 15%
FBS, transferred into 10-cm tissue culture dishes, and placed
into an incubator under hypoxic conditions (at 37 °C, 5% CO2,
5% O2). Fibroblasts expand from tissue fragments within 2–5
days and can be amplified (1:3 ratio) for up to 10 passages when
kept in hypoxia.
Construction of LOX, ADAMTS, and BMP1 constructs and
generation of stable clones for overexpression
A full-length human LOX construct in pYX-Asc vector was
obtained from Imagenes GmbH (Berlin, Germany). A full-
length human BMP1 construct in pBabe vector was kindly pro-
vided by Víctor L. Ruiz-Pe´rez (Instituto de Investigaciones Bio-
me´dicas “Alberto Sols,” Madrid, Spain) (50). Both constructs
were cloned into the vector pcDNA5/FRT/TO (Invitrogen) to
obtain the corresponding pcDNA5/FRT/TO-LOX and -BMP1
plasmids. These constructs were then co-transfected with the
Flp recombinase expression plasmid pOG44 into the Flp-In
T-REx 293 cell line using Lipofectamine 2000 (Invitrogen).
These cells stably express the Tet repressor and contain a single
integrated FRT (Flp recombination target) site. Flp recombi-
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nase expression from the pOG44 vector mediates insertion of
the cDNA cassettes into the genome at the integrated FRT site
through site-specific DNA recombination. After 48 h, cells
were selected for hygromycin B resistance (Roche Diagnostics,
Barcelona, Spain), and clones appeared after 10–15 days. Iso-
genic pooled clones were expanded and checked for transgene
expression after 48 h of incubation in the absence or presence of
doxycycline (tetracycline analog) at 1 g/ml. A construct for
the overexpression of a fusion protein of human LOX and GFP
(LOX–GFP) was generated by cloning of the LOX insert into
pEGFP-N1 (Life Technologies, Inc.) and further transfer of the
LOX–GFP chimera to pcDNA5/FRT/TO for expression in the
Flp-In T-REx 293 system. Specific mutations in the tyrosine
cluster of LOX or LOX–GFP proteins were introduced by
site-directedmutagenesis using the primer CCTACAAGTAC-
TCTGACGACAACCCTTTCTTCAACTTCTTCGATACT-
TTCGAAAGGCCCAGACCTGGGGG (changed nucleotides
shown in bold).
ADAMTS-overexpressing HEK293 cell clones were gener-
ated as described previously (15). Briefly, cells were trans-
fected (Novagen GeneJuice transfection reagent, EDMMil-
lipore, Billerica, MA) with the pcDNATM 6/TR expression
vector (Invitrogen) and selected using blasticidin. Clones
expressing a high level of the tetracycline repressor (TR)
protein were identified by immunoblotting (rabbit poly-
clonal no. TET01, MoBiTec) and further transfected by the
pcDNA4/TO expression vector (Tet-On System, Invitrogen)
containing the complete coding sequence of ADAMTS2,
ADAMTS3, or ADAMTS14 inserted in the “multiple cloning
site” (NotI–XbaI sites for ADAMTS2 and ADAMTS14 and
PmeI–PmeI sites for ADAMTS3). After selection (Zeocin, 300
g/ml), subcloning was performed to identify clones produc-
ing ADAMTS2, ADAMTS3, or ADAMTS14 only in the pres-
ence of doxycycline. Semipurified preparations of ADAMTS
enzymes were obtained as reported previously (51).
Protein analysis
To induce transgene expression in HEK293, cells were
seeded on 100-mm culture dishes and incubated at 90% conflu-
ence with 5ml of serum- and phenol red-freemedium contain-
ing 1 g/ml doxycycline (Dox) for 48 h. Cell supernatants were
collected and concentrated down to about 200l usingAmicon
Ultracentrifugal filters (Ultracel-10K, EDM Millipore). Sepa-
rately, cell monolayers were washed with PBS and lysed with
750 l of Tris-SDS buffer (60 mM Tris-HCl, pH 6.8, 2% SDS) to
obtain total-cell lysate. Protein concentration was determined
by the BCATM protein assay kit (Thermo Fisher Scientific,
Rockford, IL). For analysis of LOX expression by standard one-
dimensional (1D) electrophoresis coupled to immunoblotting,
proteins were fractionated on SDS-polyacrylamide gels. Pro-
teins were also analyzed by two-dimensional (2D) electropho-
resis. For this type of studies, samples were precipitated with
the methanol/chloroform method and then resuspended in
lysis buffer (7 M urea, 2 M thiourea, 2% CHAPS, and 1% carrier
ampholytes, pH 3–10 linear) and solubilized for 1 h at room
temperature with agitation (52). Protein concentration was
determined using PierceTM 660-nm protein assay (Thermo
Fisher Scientific). Protein extracts were diluted in rehydration
buffer (7 M urea, 2 M thiourea, 2% CHAPS, 10 mM DTT, 1,2%
DeStreak, and 1% carrier ampholytes, pH 3–11 nonlinear) up to
a final volume of 200 l and applied by active rehydration to
11-cm IPG strips, pH 3–11 NL (GE Healthcare). The first
dimension was run at 75 A/IPG strip in the IPGphor IEF Sys-
tem (GEHealthcare) following a voltage increase in eight steps.
After the first dimension, strips were equilibrated with SDS
equilibration buffer (50 mM Tris, pH 8.8, 6 M urea, 30% (v/v)
glycerol, 2% (w/v) SDS, traces of bromphenol blue) containing
1% (w/v) DTT for 12 min and thereafter in the same buffer
containing 4% (w/v) iodoacetamide for an additional 10 min.
Then the proteins were separated on home-casted 12.5% Tris-
glycine gels using an Mini Protean electrophoresis cell (Bio-
Rad) at 25 °C until the tracking dye hadmigrated off the bottom
of the gel. 1D and 2D gels were then transferred onto nitrocel-
lulose membranes at 12 V for 20 min in a semi-dry Trans-Blot
Turbo system (Bio-Rad). Membranes were blocked by incu-
bation for 30 min with 1% BSA in Tris-buffered saline (TBS)
containing 0.5% Tween 20, and antigens were detected using
specific primary antibodies (LOX: ab31238, Abcam, Cam-
bridge, UK; BMP1: AF1927, R&D Systems; anti-sulfoty-
rosine antibody: Sulfo-1C-A2, ab136481, Abcam; anti-GFP:
catalog no. 11814460001, mouse monoclonal, Roche Diag-
nostics; ADAMTS2: homemade mouse mAb recognizing the
fourth TSP1 repeat; ADAMTS3: 11-867-423-001, Roche Diag-
nostics, specific for human influenza hemagglutinin (HA)-tag
inserted in the spacer domain; ADAMTS14: sc-67436, Santa
Cruz Biotechnology, Dallas, TX). Blots were then developed
and quantified using corresponding IRDye 680- or Li-Cor
IRDye 800-labeled secondary antibodies with the Odyssey IR
imaging system (Li-Cor).
LOX–GFP proteins were immunoprecipitated using GFP-
Trap agarose beads (ChromoTek, Planegg-Martinsried, Ger-
many) following the manufacturer’s protocol. Immunoprecipi-
tated proteins were analyzed as described above. For analysis of
tyrosine sulfation, corresponding LOX–GFP-overexpressing
HEK293 cell clones were plated on 100-mm culture dishes and
grownuntil 90% confluence. Then, cells were rinsed three times
with sulfate-free medium in which 0.8 mM MgSO4 had been
replaced with 0.8 mM MgCl2. The dishes were then incubated
for 48 h at 37 °Cwith sulfate-freemediumcontaining 0.2mCi of
[32S]sulfate (PerkinElmer Life Sciences) in the presence of 1
g/ml Dox. After the incubation, the supernatants were col-
lected and processed as described above for immunoprecipita-
tion and electrophoresis analysis. Gels containing [32S]sulfate-
labeled proteins were soaked for 20 min in fixing solution (20%
acetic acid, 10%methanol) and then dried and exposed to auto-
radiographic films (Agfa Healthcare, Mortsel, Belgium) or
using a Fujifilm BAS-1500 phosphorimager (Fuji Photo Film
Co. Ltd., Kanagawa, Japan).
Proteomic analysis
For analysis of the proteolytic processing site of LOX by
ADAMTS2 enzyme, LOX supernatants were exposed to the
protease for 4 h at 37 °C and then filtered through a 50-kDa
cutoff Amicon ultracentrifugal filter (Ultracel-50K, Millipore)
to enrich the sample in low-molecular weight polypeptides.
Eluates were then applied onto 1.2-cm wide wells of a conven-
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tional SDS-polyacrylamide gel (0.75-mm thick, 4% stacking,
and 10% resolving). Electrophoresis was continued until the
proteins became concentrated at the stacking/resolving gel
interface. The unseparated protein bands were visualized by
Coomassie staining, excised, cut into cubes (2  2 mm), and
placed in 0.5-ml microcentrifuge tubes. The gel pieces were
destained in acetonitrile/water (1:1), incubated with 10 mM
DTT for 1 h at 56 °C for disulfide bond reduction and with 50
mM iodoacetamide for 1 h at room temperature in darkness for
thiol group alkylation, and then digested in situ with sequenc-
ing grade trypsin (Promega, Madison, WI) as described previ-
ously (53). Digestion products were desalted onto OMIX
PipetteC18 tips (AgilentTechnologies) and analyzed by reverse
phase-LC–tandemMS (RP-LC-MS/MS) in an Easy-nLC II sys-
tem coupled to an ion trap linear trap quadrupole (LTQ)-Or-
bitrap-Velos-Pro hybrid mass spectrometer (Thermo Fisher
Scientific). Peptide identification from raw data were carried
out using PEAKS Studio 6 software (Bioinformatics Solutions
Inc.) (54). Database search was performed against UniProt-
Homo sapiens.fasta (decoy-fusion database). The following
constraints were used for the searches: tryptic cleavage after
Arg and Lys, up to twomissed cleavage sites, allows nonspecific
cleavage at one end of the peptide, and tolerances of 20 ppm for
precursor ions and 0.6 Da for MS/MS fragment ions. The vari-
ablemodifications allowedweremethionine oxidation and cys-
teine carbamidomethylation. False discovery rate (FDR)was set
as1% (FDR 0.01). Detected LOX sequences were screened
for nontryptic internal peptides (no Lys or Arg in P1) as poten-
tial sites for ADAMTS processing.
To characterize the potential modification by tyrosine sulfa-
tion, LOX–GFP supernatants were exposed to BMP1 protease
and immunoprecipitated with GFP-Trap agarose beads as
described above. Afterward, immunoprecipitates were then
fractioned by SDS-PAGE and analyzed by immunoblotting
with anti-GFP antibody and stained for total protein with Coo-
massie Blue.Gel bandsmatchingLOX–GFPprecursor andpro-
cessed forms were excised from the gel and manually digested
with sequencing-grade AspN (Promega). For this digestion, gel
plugs were alternatively washed several times with 25 mM
ammonium bicarbonate and acetonitrile; thereafter, samples
were reduced with 10 mM DTT for 1 h at 37 °C, followed by
alkylation with 55 mM iodoacetamide for 30 min at room tem-
perature before incubating with 0.1 g of AspN for 18 h at
37 °C. Following digestion, peptides were extracted, pooled,
dried by speed-vacuum centrifugation, and resuspended in
0.2% TFA in water for PRM analysis using an Eksigent
1D-nanoHPLC coupled to a 5600TripleTOF QTOF mass
spectrometer (Sciex, Framingham,MA), equippedwith a nano-
ESI source and controlled by Analyst version 1.7 software
(ABSciex). HPLC was equipped with a trap column Acclaim
PepMap 100, 5-mparticle diameter, 100 Å pore size (Thermo
Fisher Scientific), switched on-linewith a silica-based reversed-
phase column nanoACQUITY UPLC 75 m 15 cm, 1.7-m
particle size (Waters). The loading pumpdelivered a solution of
0.1% formic acid in 98% water, 2% acetonitrile (Scharlab, Bar-
celona, Spain) at 3l/min. The nanopump provided a flow rate
of 250 nl/min and was operated under gradient elution condi-
tions, using 0.1% formic acid in water as mobile phase A and
0.1% formic acid in 100% acetonitrile as mobile phase B. Gradi-
ent elution was performed according to the following scheme:
isocratic conditions of 96% A and 4% B for 5 min, a linear
increase to 40% B in 25min, a linear increase to 95% B in 2min,
isocratic conditions of 95% B for 5 min, and return to initial
conditions in 10 min. Injection volume was 5 l.
The LC system was coupled via a nanospray source to the
mass spectrometer. PRM analysis was conducted in negative
ion mode with the ion spray voltage set at 2800 V. Initial PRM
tests were also performed in positive ionmode. Drying gas tem-
perature was set to 150 °C at a flow rate of 20 liters/min. Full
scanMS spectra (m/z 230–1500) were acquired during 100ms.
Product ion scans of precursors withm/z values of 611.7, 651.8,
and 691.8, corresponding to the unmodified, monosulfonated,
and disulfonated variants ofDDNPYYNYY (M 2H), respec-
tively, were acquired during 100ms/cycle in the 100–1500m/z
range. Acquisition mode was of high-sensitivity, and both MS
and MSMS spectra were analyzed using PeakView version 1.2
software (Sciex).
Sulfated synthetic DDNPYYNYY peptides were used to val-
idate PRN analysis and to confirm the sequence identity. These
peptides were synthesized in-house using standard Fmoc
(N-(9-fluorenyl)methoxycarbonyl) chemistry in an Intavis
Multiple peptide synthesizer (INTAVIS, Cologne, Germany).
Analysis of LOX enzymatic activity
LOX supernatants were assayed for enzymatic activity using
the lysyl oxidase activity assay kit (Fluorometric) from Abcam.
This assay is based on the widely used method described by
Palamakumbura et al. (22) and uses a proprietary soluble LOX
substrate in a horseradish peroxidase–coupled reaction with
concomitant detection of hydrogen peroxide with Amplex Red
reagent. Briefly, 50 l of concentrated supernatant were mixed
with an equivalent volume of reaction mixture in the presence
or absence of 0.3 mM BAPN, a pan-inhibitor of lysyl oxidases.
H2O2 release was measured every 3min for a total period of 1 h
at excitation and emission wavelengths of 525 and 580–640
nm, respectively, on a Glomax Multi Detection system (Pro-
mega). Enzyme activities were expressed as fluorescence arbi-
trary units and corrected for background levels determined in
the presence of BAPN.
Solid-phase binding assay
Binding of the various LOX species to collagen was per-
formed by a modification of the standard solid-phase binding
assay (55). Telocollagen (RatCol, rat tail type I collagen solu-
tion) and atelocollagen (Nutragen, bovine type I collagen solu-
tion) (Advanced Biomatrix, San Diego) were coated overnight
on Maxisorb 96-well-immunoplates (Nunc, Thermo Fisher
Scientific) at 50 g/ml in 16 mM acetic acid buffer and washed
three times with HBS buffer (10 mM HEPES, 0.135 M NaCl, pH
7.4). Afterward, wells were blocked with 3% BSA in HBS buffer
for 1 h andwashed three times before the incubationwith LOX-
containing concentrated supernatants for 1 h at room temper-
ature in HBS buffer containing 2 mM CaCl2 and 15 M ZnSO4.
Unbound proteins were extensively washed out with HBS
buffer, and the remaining boundmaterial was removed by addi-
tion of 30 ml of SDS-loading buffer and 5 min heating at 60 °C.
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Unbound and bound fractions were then analyzed for LOX
immunoreactivity by immunoblotting as described above. LOX
proteins were quantified by densitometry, and the extent of
binding was expressed as percentage of total.
Statistical analysis
Data are presented as the mean  S.D. of n independent
measurements as indicated in the corresponding figure leg-
ends. Statistical comparisons between groups were calculated
by one-way ANOVA analysis followed by Bonferroni’s post test
for multiple-group comparisons using GraphPad Prism 6. The
p values obtained are indicated in the figure legends when sta-
tistically significant (p 0.05).
Protein alignments were performed with Clustal Omega at
the European Bioinformatics Institute (EMBL-EBI) using
sequences available in the NCBI (National Center for Biotech-
nology Information) protein database.
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